Éric Quéméneur

2.9k total citations
102 papers, 2.3k citations indexed

About

Éric Quéméneur is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Éric Quéméneur has authored 102 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 35 papers in Genetics and 27 papers in Oncology. Recurrent topics in Éric Quéméneur's work include Virus-based gene therapy research (30 papers), CAR-T cell therapy research (16 papers) and Cancer Research and Treatments (14 papers). Éric Quéméneur is often cited by papers focused on Virus-based gene therapy research (30 papers), CAR-T cell therapy research (16 papers) and Cancer Research and Treatments (14 papers). Éric Quéméneur collaborates with scholars based in France, Italy and United Kingdom. Éric Quéméneur's co-authors include Claude Vidaud, Mireille Moutiez, Olivier Pible, Frédéric Bérenguer, Andre Ménèz, Odette Prat, Paul Guéguen, Christian Basset, Véronique Malard and Frédéric Cédrone and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Éric Quéméneur

97 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Éric Quéméneur France 29 1.2k 521 435 347 259 102 2.3k
Mark D. Carr United Kingdom 29 1.7k 1.4× 823 1.6× 245 0.6× 170 0.5× 578 2.2× 69 3.4k
Curt A. Davey Singapore 28 3.7k 3.1× 806 1.5× 202 0.5× 162 0.5× 377 1.5× 45 4.9k
Raffaele Petruzzelli Italy 29 1.5k 1.3× 305 0.6× 119 0.3× 297 0.9× 97 0.4× 88 2.8k
Shaodong Dai United States 30 1.5k 1.3× 292 0.6× 205 0.5× 243 0.7× 902 3.5× 61 2.9k
Weimin Gong China 35 3.2k 2.7× 375 0.7× 415 1.0× 132 0.4× 122 0.5× 130 4.2k
Domenico Bordo Italy 28 1.5k 1.3× 262 0.5× 162 0.4× 107 0.3× 237 0.9× 57 2.6k
Steven M. Yannone United States 23 1.7k 1.4× 387 0.7× 151 0.3× 88 0.3× 128 0.5× 42 2.3k
Emily Flashman United Kingdom 34 2.2k 1.8× 192 0.4× 375 0.9× 327 0.9× 123 0.5× 68 3.5k
Millie M. Georgiadis United States 28 2.5k 2.1× 360 0.7× 189 0.4× 160 0.5× 89 0.3× 79 3.3k
P Aisen United States 28 1.6k 1.3× 499 1.0× 173 0.4× 440 1.3× 240 0.9× 51 4.3k

Countries citing papers authored by Éric Quéméneur

Since Specialization
Citations

This map shows the geographic impact of Éric Quéméneur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Quéméneur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Quéméneur more than expected).

Fields of papers citing papers by Éric Quéméneur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Éric Quéméneur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Quéméneur. The network helps show where Éric Quéméneur may publish in the future.

Co-authorship network of co-authors of Éric Quéméneur

This figure shows the co-authorship network connecting the top 25 collaborators of Éric Quéméneur. A scholar is included among the top collaborators of Éric Quéméneur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Quéméneur. Éric Quéméneur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tourneau, Christophe Le, Jean‐Pierre Delord, Ana I. Lalanne, et al.. (2024). 650 Randomized phase I trial of adjuvant individualized TG4050 vaccine in patients with locally advanced resected HPV-negative head and neck squamous cell carcinoma (HNSCC). Regular and Young Investigator Award Abstracts. A746–A746. 1 indexed citations
2.
Marquette, Christophe A., Emma Petiot, Philippe Erbs, et al.. (2024). 3D bioprinted CRC model brings to light the replication necessity of an oncolytic vaccinia virus encoding FCU1 gene to exert an efficient anti-tumoral activity. Frontiers in Oncology. 14. 1384499–1384499. 1 indexed citations
3.
Fend, Laetitia, Michel Geist, Nathalie Silvestre, et al.. (2023). Design and selection of anti-PD-L1 single-domain antibody and tumor necrosis factor superfamily ligands for an optimal vectorization in an oncolytic virus. Frontiers in Bioengineering and Biotechnology. 11. 1247802–1247802. 1 indexed citations
4.
Seitlinger, Joseph, Julien Demiselle, Ysia Idoux‐Gillet, et al.. (2023). Patient-Derived Tumoroid for the Prediction of Radiotherapy and Chemotherapy Responses in Non-Small-Cell Lung Cancer. Biomedicines. 11(7). 1824–1824. 2 indexed citations
5.
McGuckin, Colin, Nico Forraz, Yordan Sbirkov, et al.. (2023). World’s First Long-Term Colorectal Cancer Model by 3D Bioprinting as a Mechanism for Screening Oncolytic Viruses. Cancers. 15(19). 4724–4724. 11 indexed citations
6.
Seitlinger, Joseph, Véronique Lindner, Anne Olland, et al.. (2022). Patient-Derived Lung Tumoroids—An Emerging Technology in Drug Development and Precision Medicine. Biomedicines. 10(7). 1677–1677. 7 indexed citations
7.
Mencattini, Arianna, Philippe Erbs, Jean‐Marc Balloul, et al.. (2022). Direct imaging and automatic analysis in tumor-on-chip reveal cooperative antitumoral activity of immune cells and oncolytic vaccinia virus. Biosensors and Bioelectronics. 215. 114571–114571. 24 indexed citations
8.
Gantzer, Murielle, Johann Foloppe, Bernard Klonjkowski, et al.. (2021). Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs. Scientific Reports. 11(1). 2209–2209. 7 indexed citations
9.
Fend, Laetitia, Takahiro Yamazaki, Murielle Gantzer, et al.. (2017). Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy. Cancer Research. 77(15). 4146–4157. 108 indexed citations
10.
Bendjama, Kaïdre & Éric Quéméneur. (2017). Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer. Human Vaccines & Immunotherapeutics. 13(9). 1997–2003. 6 indexed citations
11.
Prat, Odette, et al.. (2011). From cell to man: Evaluation of osteopontin as a possible biomarker of uranium exposure. Environment International. 37(4). 657–662. 13 indexed citations
12.
Bellanger, Laurent, Patrick Hivin, Éric Quéméneur, et al.. (2010). Characterisation of the purified human sodium/iodide symporter reveals that the protein is mainly present in a dimeric form and permits the detailed study of a native C-terminal fragment. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1808(1). 65–77. 19 indexed citations
13.
Malard, Véronique, et al.. (2009). Urine proteomic profiling of uranium nephrotoxicity. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1794(6). 882–891. 38 indexed citations
14.
Estrabaud, Emilie, Irina Lassot, Guillaume Blot, et al.. (2007). RASSF1C, an Isoform of the Tumor Suppressor RASSF1A, Promotes the Accumulation of β-Catenin by Interacting with βTrCP. Cancer Research. 67(3). 1054–1061. 47 indexed citations
15.
Malard, Véronique, et al.. (2005). Proteomic analysis of the response of human lung cells to uranium. PROTEOMICS. 5(17). 4568–4580. 44 indexed citations
16.
Armengaud, Jean, et al.. (2005). Deciphering structure and topology of conserved COG2042 orphan proteins.. BMC Structural Biology. 5(1). 3–3. 7 indexed citations
17.
Couprie, Joël, Béatrice Alpha‐Bazin, Vincent Meyer, et al.. (2004). The Tudor Tandem of 53BP1. Structure. 12(9). 1551–1562. 83 indexed citations
18.
Gadal, Olivier, Stéphane Chédin, Éric Quéméneur, et al.. (1997). A34.5, a Nonessential Component of Yeast RNA Polymerase I, Cooperates with Subunit A14 and DNA Topoisomerase I To Produce a Functional rRNA Synthesis Machine†. Molecular and Cellular Biology. 17(4). 1787–1795. 64 indexed citations
19.
Guéguen, Paul, et al.. (1996). ATP Binding and Hydrolysis by the Multifunctional Protein Disulfide Isomerase. Journal of Biological Chemistry. 271(5). 2663–2666. 29 indexed citations
20.
Belin, Pascal, Éric Quéméneur, & P Boquet. (1994). A pleîotropic acid phosphatase-deficient mutant of Escherichia coli shows premature termination in the dsbA gene. Use of dsbA :: phoA furions to localize a structurally important domain in DsbA. Molecular and General Genetics MGG. 242(1). 23–32. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026